Provectus Biopharmaceuticals, Inc. financial statements, including revenue, expenses, and profit
The total revenue of PVCT for the last quarter is 14.33 k USD, and it's 86.94% lower compared to the previous quarter. The net income of Q4 24 is -2.37 M USD.